Bartonellosis/Cat Scratch Disease (Bartonella henselae)
For the why behind the fact
Use this page to connect what you are memorizing.
Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.
Overview
Plain-Language Overview
Cat-scratch disease is an infection usually caused by Bartonella henselae. A small skin bump may follow a cat scratch or bite, then nearby lymph nodes become swollen and tender. Most otherwise healthy people recover over weeks to months, though eye, neurologic or other organ complications can occur. Bartonellosis is the broader name for infections caused by Bartonella species; cat-scratch disease is one form.
Clinical Definition
Bartonellosis/Cat Scratch Disease is a self-limited infectious disease caused by the gram-negative bacillus Bartonella henselae, transmitted primarily through cat scratches or bites. The core pathology involves a localized granulomatous lymphadenitis typically affecting regional lymph nodes proximal to the inoculation site. The infection triggers a cell-mediated immune response resulting in lymph node enlargement, tenderness, and sometimes suppuration. Systemic symptoms such as fever, malaise, and fatigue are common, and rare complications include parinaud oculoglandular syndrome, neuroretinitis, and hepatosplenic involvement. Diagnosis is clinically suspected based on exposure history and characteristic lymphadenopathy, with confirmation by serologic testing or PCR. The disease is significant due to its potential to mimic malignancy or other infections and its occasional severe manifestations in immunocompromised hosts.
Inciting Event
Cat scratch or bite introduces Bartonella henselae into the skin.
Contact with cat saliva on broken skin or mucous membranes can transmit the bacteria.
Cat fleas spread infection among cats; flea feces on claws can contaminate a scratch. Direct transmission to people by flea bites has not been proven.
Handling kittens increases exposure due to higher bacterial load in young cats.
Inoculation requires a route such as a contaminated scratch, bite or saliva contacting broken skin; touching fur alone is not the usual route.
Latency Period
3 to 10 days from inoculation to development of primary skin lesion (papule or pustule).
1 to 3 weeks from inoculation to onset of regional lymphadenopathy.
Fever and malaise may accompany the nodal illness; there is no single required 2-4-week onset for systemic symptoms.
Disseminated disease can have an atypical or prolonged course; immunocompromise does not establish a specific longer incubation period.
Diagnostic Delay
Nonspecific symptoms such as fever and malaise often mimic viral infections, delaying diagnosis.
Lack of awareness of cat exposure history leads to missed clinical suspicion.
Misattribution of lymphadenopathy to bacterial lymphadenitis or malignancy causes diagnostic confusion.
Negative routine bacterial cultures delay identification since Bartonella henselae is fastidious.
Serologic testing limitations and variable sensitivity can complicate confirmation.
Clinical Presentation
Signs & Symptoms
Localized papule or pustule at the site of cat scratch or bite within 1-2 weeks.
Regional lymphadenopathy that is tender and may suppurate, typically in axillary or cervical nodes.
Low-grade fever, malaise, and fatigue are common systemic symptoms.
Parinaud oculoglandular syndrome presents with conjunctivitis and ipsilateral lymphadenopathy.
Rarely, hepatosplenic involvement causes abdominal pain and systemic symptoms.
History of Present Illness
Initial papule or pustule at inoculation site develops within days after cat scratch or bite.
Progressive regional lymphadenopathy appears 1 to 3 weeks later, often tender and unilateral.
Associated low-grade fever, malaise, and fatigue are common systemic symptoms.
Lymph nodes may become fluctuant or suppurative in some cases.
In immunocompromised patients, disseminated symptoms such as hepatosplenomegaly or bacillary angiomatosis may occur.
Past Medical History
History of immunosuppressive conditions such as HIV/AIDS or organ transplantation increases risk of severe disease.
Previous cat exposure or ownership is relevant for epidemiologic context.
Persistent nodes may last months after typical CSD; prior unexplained lymphadenitis alone does not establish recurrent active Bartonella infection.
No specific genetic predisposition is known, but immunodeficiency syndromes may worsen course.
History of flea infestations in household cats may increase transmission risk.
Family History
No known heritable syndromes are associated with susceptibility to cat scratch disease.
Family members with shared cat exposure may have similar risk of infection.
No familial clustering of immune defects specifically linked to Bartonella infection has been described.
Genetic predisposition to severe disease has not been established.
Family history is generally noncontributory in typical cases.
Physical Exam Findings
Tender regional lymphadenopathy near the site of cat scratch or bite is the hallmark finding.
Papule or pustule at the inoculation site appearing 3-10 days after exposure.
Low-grade fever and malaise may be present during the acute phase.
Conjunctivitis or Parinaud oculoglandular syndrome if the eye is involved.
Hepatosplenomegaly can be detected in disseminated cases.
Diagnostic Workup
Diagnostic Criteria
Typical CSD is diagnosed from compatible exposure, inoculation lesion and regional lymphadenopathy after considering alternatives. Serology supports but does not by itself prove active disease: cross-reactions and persistent antibodies occur. PCR on suitable node material may help when sampling is warranted; blood PCR and negative tests have limited sensitivity. Necrotizing granulomas with stellate microabscesses support the diagnosis but are not unique to CSD. Biopsy is reserved for atypical/persistent disease or diagnostic uncertainty.
Pathophysiology
Key Mechanisms
Intracellular infection of endothelial cells and macrophages by Bartonella henselae leads to localized inflammation and granuloma formation.
Lymphatic spread from the site of inoculation causes regional lymphadenopathy.
Immune-mediated granulomatous response results in necrotizing lymphadenitis with stellate microabscesses.
Endothelial proliferation induced by bacterial factors can cause angioproliferative lesions in immunocompromised hosts.
Bacterial evasion of host immunity through inhibition of phagosome-lysosome fusion promotes persistence.
| Involvement | Details |
|---|---|
| Organs | Lymph nodes are commonly enlarged and tender due to regional lymphadenitis in cat scratch disease. |
Skin serves as the initial site of Bartonella henselae inoculation and local lesion development. | |
Liver and spleen can develop granulomatous lesions in disseminated CSD, including in immunocompetent patients. | |
| Tissues | Lymph node tissue is the primary site of granulomatous inflammation and necrosis in cat scratch disease. |
Skin tissue at the inoculation site shows papule or pustule formation due to local bacterial infection. | |
Vascular tissue involvement occurs in bacillary angiomatosis, causing proliferative vascular lesions. | |
| Cells | Macrophages/histiocytes contribute to the granulomatous host response; experimental intracellular survival does not make them a proven universal long-term human reservoir. |
Endothelial infection and proliferation are central to bacillary angiomatosis, distinct from the necrotizing granulomatous lymphadenitis of typical CSD. | |
Lymphocytes mediate the immune response causing regional lymphadenopathy characteristic of cat scratch disease. | |
| Chemical Mediators | Interleukin-1 (IL-1) is elevated and contributes to local inflammation and fever in cat scratch disease. |
Tumor necrosis factor-alpha (TNF-α) promotes granuloma formation and systemic symptoms. | |
Angiogenic signaling contributes to bacillary angiomatosis; the bacterial factor BafA can directly activate VEGFR2, acting as a VEGF analog in experimental studies. |
Treatments
Pharmacological Treatments
Azithromycin
- Mechanism:
Inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit of Bartonella henselae.
- Side effects:
Gastrointestinal upset
QT prolongation
Allergic reactions
- Clinical role:
A 5-day course may be offered for typical CSD depending on severity/preferences; many healthy patients recover without antibiotics. This is not sufficient management for disseminated disease or all immunocompromised hosts.
Doxycycline
- Mechanism:
Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, effective against Bartonella henselae.
- Side effects:
Photosensitivity
Gastrointestinal upset
Pill esophagitis and age/duration-specific dental considerations; brief pediatric courses do not show the classic tetracycline staining risk.
- Clinical role:
Used for selected systemic/ocular/neurologic disease, often with another agent. In HIV-associated bartonellosis, doxycycline or erythromycin is preferred and treatment generally lasts at least 3 months under specialist care.
Rifampin
- Mechanism:
Inhibits bacterial DNA-dependent RNA polymerase, used in combination therapy for severe cases.
- Side effects:
Hepatotoxicity
Orange discoloration of body fluids
Drug interactions
- Clinical role:
Combination partner for selected severe, neurologic, ocular or endocarditis presentations; regimen and duration are organ- and host-specific, with interaction review.
Non-pharmacological Treatments
Typical uncomplicated disease in an immunocompetent patient often needs observation and symptom relief; reassess persistent fever, vision changes or other organ symptoms.
Consider needle aspiration for severe pain/swelling from a suppurative node or diagnostic uncertainty; routine aspiration or open surgical drainage is not required.
Ocular, neurologic, cardiac or disseminated disease needs specialist evaluation and directed therapy; exposure prevention does not treat an established infection.
Prevention
Pharmacological Prevention
No established antibiotic prophylaxis is recommended after cat exposure.
Azithromycin is treatment, not prophylaxis: a small trial showed faster early node-volume reduction, without demonstrated improvement in overall outcomes. Cat-bite wound prophylaxis for other bacteria is a separate assessment.
Non-pharmacological Prevention
Avoid rough play with cats to reduce scratches and bites.
Wash cat scratches or bites immediately with soap and water to reduce bacterial inoculation.
Control flea infestations in cats to decrease Bartonella henselae transmission.
Educate immunocompromised patients to avoid contact with stray or young cats.
Outcome & Complications
Complications
Suppurative lymphadenitis requiring drainage.
Neuroretinitis causing vision loss in ocular involvement.
Bacillary angiomatosis in immunocompromised patients presenting with vascular skin lesions.
Hepatosplenic granulomatous disease in disseminated infection.
Endocarditis is a rare but serious complication.
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Bartonellosis/Cat Scratch Disease (Bartonella henselae) versus Lymphadenitis due to Staphylococcus aureus or Streptococcus pyogenes
Bartonellosis/Cat Scratch Disease (Bartonella henselae) | Lymphadenitis due to Staphylococcus aureus or Streptococcus pyogenes |
|---|---|
History of cat scratch or bite preceding lymphadenopathy | Recent skin trauma or local infection with purulent drainage |
Subacute regional nodes can become fluctuant and suppurative. | Often more acute with erythema/tenderness; fluctuation is shared and not a definitive discriminator. |
Often self-limited; selected typical cases receive azithromycin, while complicated disease needs tailored therapy. | Treat likely staphylococci/streptococci with locally appropriate coverage, including MRSA when indicated, and drain a true pyogenic collection when needed. |
Bartonellosis/Cat Scratch Disease (Bartonella henselae) versus Tuberculous lymphadenitis
Bartonellosis/Cat Scratch Disease (Bartonella henselae) | Tuberculous lymphadenitis |
|---|---|
Cat contact supports CSD but does not exclude simultaneous TB exposure. | TB contact or relevant residence/travel supports risk; absence of a recalled contact does not exclude TB. |
Subacute suppurative necrotizing granulomatous lymphadenitis with stellate microabscesses. | Often chronic granulomatous lymphadenitis with caseation, but histology varies and overlaps. |
Compatible serology/PCR supports CSD in context; neither is uniformly sensitive. | Node culture/NAAT and histology support TB; an AFB stain is not species-specific and a negative smear does not exclude it. |
Bartonellosis/Cat Scratch Disease (Bartonella henselae) versus Toxoplasmosis lymphadenitis
Bartonellosis/Cat Scratch Disease (Bartonella henselae) | Toxoplasmosis lymphadenitis |
|---|---|
Direct cat scratch or bite exposure | Exposure to undercooked meat or cat feces in immunocompetent host |
Granulomatous inflammation with stellate microabscesses | Follicular hyperplasia with clusters of epithelioid histiocytes without necrosis |
Bartonella serology/PCR interpreted with clinical features. | Toxoplasma IgG/IgM patterns and confirmatory testing are interpreted together; isolated positive IgM may persist or be false-positive. |
Bartonellosis/Cat Scratch Disease (Bartonella henselae) versus Tularemia
Bartonellosis/Cat Scratch Disease (Bartonella henselae) | Tularemia |
|---|---|
Exposure to cats or kittens | Exposure to rabbits, ticks, or deer flies in endemic regions |
Infection with Bartonella henselae | Infection with Francisella tularensis |
Often an inoculation papule followed by regional nodes; lesion appearance varies and may no longer be visible. | Ulceroglandular tularemia has a local ulcer, but glandular tularemia may lack one. |
Bartonellosis/Cat Scratch Disease (Bartonella henselae) versus Lymphoma
Bartonellosis/Cat Scratch Disease (Bartonella henselae) | Lymphoma |
|---|---|
Often tender regional nodes after cat exposure, but atypical painless or persistent nodes occur. | Often painless progressive nodes, but pain or preceding infection does not exclude lymphoma. |
Reactive granulomatous/suppurative histology may support CSD. | Diagnosis requires appropriate tissue morphology/immunophenotyping; normal blood counts do not exclude lymphoma. |
Usually regional lymphadenopathy, though disseminated patterns occur. | Lymphoma may be localized or generalized; distribution alone is not diagnostic. |